Author

Zahra Verwer

Observed name: Z. Verwer

Institution: The Netherlands Cancer Institute

Observed institution: The Netherlands Cancer Institute

OpenAlex ID: A5116887342

Independent Dutch Validation Study of CP-GEP (Merlin Assay) for the Prediction of Nodal Metastasis and Long-Term Outcome in Patients with Primary Cutaneous Melanoma

2025 · Lisanne P. Zijlker, Zahra Verwer, et al. · Annals of Surgical Oncology · 2

PB3802 Incidence and management of treatment failure in pulmonary embolism patients treated in a single EXPERT-PE tertiary referral center

2026 · Wilhelmina Stenger, Linde op de Hoek, et al. · Research and Practice in Thrombosis and Haemostasis

PB3825 Clinical outcomes and treatment decisions in patients with severe acute pulmonary embolism: findings from a single EXPERT-PE tertiary referral center in the Netherlands

2026 · Linde op de Hoek, Wilhelmina Stenger, et al. · Research and Practice in Thrombosis and Haemostasis

ASO Visual Abstract: Independent Dutch Validation Study of CP-GEP (Merlin Assay) for the Prediction of Nodal Metastasis and Long-Term Outcome in Primary Cutaneous Melanoma Patients

2026 · Lisanne P. Zijlker, Zahra Verwer, et al. · Annals of Surgical Oncology

Clinicopathologic and gene expression profile (CP-GEP) is a biomarker for outcome in patients with melanoma eligible for sentinel lymph node biopsy (SLNB)

2025 · L. Zijlker, Z. Verwer, et al. · EJC Skin Cancer

Works count: 5

Citation count: 2

H-index: 1

I10-index: